« Previous
Next »
Journal of Dermatological Science
Volume 60, Issue 1
, Pages 52-54
, October 2010
Serum TARC/CCL17 levels are increased in dermatomyositis associated with interstitial lung disease
References
- . Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292(7):344–347
- . Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975;292(8):403–407
- The role of the Th2 CC chemokine ligand CCL17 in pulmonary fibrosis. J Immunol. 2004;173(7):4692–4698
- Elevated expression of TARC (CCL17) and MDC (CCL22) in models of cigarette smoke-induced pulmonary inflammation. Biochem Biophys Res Commun. 2005;334(1):254–262
- Pathogenesis of cBFL in common with IPF? Correlation of IP-10/TARC ratio with histological patterns. Thorax. 2008;63(9):810–816
- . A novel mechanism for CCR4 in the regulation of macrophage activation in bleomycin-induced pulmonary fibrosis. Am J Pathol. 2008;172(5):1209–1221
- . Serum levels of a Th1 chemoattractant IP-10 and Th2 chemoattractants, TARC and MDC, are elevated in patients with systemic sclerosis. J Dermatol Sci. 2004;35(1):43–51
- KL-6 as a novel serum marker for interstitial pneumonia associated with collagen diseases. J Rheumatol. 2000;27(5):1164–1170
- Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am J Respir Crit Care Med. 2000;162(3 Pt 1):1109–1114
- Clinical significance of serum surfactant protein D (SP-D) in patients with polymyositis/dermatomyositis: correlation with interstitial lung disease. Rheumatology (Oxford). 2002;41(11):1268–1272
PII: S0923-1811(10)00234-3
doi: 10.1016/j.jdermsci.2010.07.012
© 2010 Japanese Society for Investigative Dermatology. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Dermatological Science
Volume 60, Issue 1
, Pages 52-54
, October 2010
